The intestinal bacterial colonisation in preterm infants: a review of the literature

Elisabeth A M Westerbeek1, Anemone van den Berg, Harrie N Lafeber

  • 1Department of Pediatrics, Subdivision of Neonatology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Insights

Preterm infants often have delayed gut colonization by beneficial bacteria, increasing infection risk. Strategies to promote healthy intestinal microflora are crucial for these vulnerable infants.

Area of Science:

  • Neonatal research
  • Microbiology
  • Pediatric medicine

Background:

  • Preterm infants exhibit increased intestinal permeability and immature immune systems, elevating risks of bacterial translocation and systemic infections.
  • The intestinal microflora of healthy, breast-fed term infants, rich in bifidobacteria and lactobacilli, is crucial for suppressing pathogenic bacterial growth.
  • Altering diet with prebiotics and probiotics aims to enhance beneficial bacteria in the infant gut.

Purpose of the Study:

  • To review the normal development of intestinal microflora in preterm infants.
  • To identify factors influencing the intestinal microflora development in preterm infants.
  • To assess the impact of interventions and antibiotics on gut colonization in preterm neonates.

Main Methods:

  • Systematic review of six selected studies on intestinal bacterial colonization in preterm infants.
  • Analysis of factors affecting microflora development, including feeding practices and antibiotic use.
  • Evaluation of strategies to promote beneficial bacteria like bifidobacteria and lactobacilli.

Main Results:

  • Intestinal bacterial colonization with beneficial bacteria is generally delayed in preterm infants.
  • Preterm infants show a higher prevalence of potentially pathogenic bacteria in their gut.
  • Antibiotic use, particularly prophylactic broad-spectrum antibiotics, significantly impacts and delays normal intestinal colonization.

Conclusions:

  • Delayed colonization and a higher load of pathogenic bacteria pose risks to preterm infants.
  • Interventions like prebiotics and probiotics show potential but require careful consideration.
  • Judicious use and restricted duration of broad-spectrum antibiotics are recommended to support healthy gut microbiome development in preterm neonates.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...